Recurrent salivary gland carcinomas treated by surgery with or without intraoperative radiation therapy

Head and Neck

Volumn 30, Issue 1, 2008, Pages 2-9

  Chen, Allen M ^a   Garcia, Joaquin ^a   Bucci, M Kara ^b   Chan, Albert S ^a   Kaplan, Michael J ^c   Singer, Mark I ^a   Phillips, Theodore L ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Intraop Medical Inc   (United States)

Author keywords

Carcinoma; Intraoperative radiation; Recurrent; Salivary gland; Surgery

Indexed keywords

ADULT; ARTICLE; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; ETHNICITY; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HUMAN; INTRAOPERATIVE RADIOTHERAPY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RADIATION DOSE; RECURRENT CANCER; SALIVARY GLAND; SALIVARY GLAND CARCINOMA; SALVAGE THERAPY; STATISTICAL ANALYSIS; TREATMENT FAILURE; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INTRAOPERATIVE CARE; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY, ADJUVANT; RECURRENCE; RETROSPECTIVE STUDIES; SALIVARY GLAND NEOPLASMS; SALVAGE THERAPY;

EID: 38549153313     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.20651     Document Type: Article

References (33)

1. Mendenhall WM, Morris CG, Amdur RJ, Wernig JW, Villaret DB. Radiotherapy alone or combined with surgery for salivary gland carcinoma. Cancer 2005;103:2544-2550.
2. Le QT, Birdwell S, Terris DJ, et al. Postoperative irradiation of minor salivary gland malignancies of the head and neck. Radiother Oncol 1999;52:165-171.
3. Garden AS, El-Naggar AK, Morrison WH, Callendar DL, Ang KK, Peters LJ. Postoperative radiotherapy for malignant tumors of the parotid gland. Int J Radiat Oncol Biol Phys 1997;37:79-85.
4. De Crevoisier R, Domenge C, Wibault P, et al. Full-dose reirradiation for unresectable head and neck carcinoma: experience at the Gustave-Roussy Institute in a series of 169 patients. J Clin Oncol 1998;16:3556-3562.
5. Ling SM, Roach M, Fu KK, et al. Local control after the use of adjuvant electron beam intraoperative radiotherapy in patients with high-risk head and neck cancer: the UCSF experience. Cancer J Sci Am 1996;2:321-329.
6. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:547-581.
7. Cox DR, Oakes N. Analysis of survival data. New York, NY: Chapman and Hall; 1988.
8. Honk WK, Bromer RH, Amato DA, et al. Patterns of relapse in locally advanced head and neck cancer patients who achieved complete remission after combined modality treatment. Cancer 1985;45:1242-1245.
9. Armstrong JG, Harrison LB, Spiro RH, Fass DE, Strong EW, Fuks ZY. Observation on the natural history and treatment of recurrent major salivary gland cancer. J Surg Oncol 1990;44:138-141.
10. King JJ, Fletcher GH. Malignant tumors of the major salivary glands. Radiology 1971;100:381-384.
11. Buchholz TA, Laramore GE, Griffin BR, Koh WJ, Griffin TW. The role of fast neutron radiation therapy in the management of advanced salivary gland malignant neoplasms. Cancer 1992;9:2779-2788.
12. Armstrong JG, Harrison LB, Spiro RH, et al. Brachytherapy of malignant tumors of salivary gland origin. Endocurither Hypertherm Oncol 1996;6:19-22.
13. Argiris A, Li Y, Forastiere A. Prognostic factors and long-term survivorship in patients with recurrent or metastatic carcinoma of the head and neck. Cancer 2004;101:2222-2229.
14. Taussky D, Dulguerov P, Allal AS. Salvage surgery after radical accelerated radiotherapy with concomitant boost technique for head and neck carcinomas. Head Neck 2005;27:182-186.
15. Wong LY, Wei WI, Lam LK, Yuen AP. Salvage of recurrent head and neck squamous cell carcinoma after primary curative surgery. Head Neck 2003;25:953-959.
16. Freeman SB, Hamaker RC, Singer MI, Pugh N, Garrett P, Ross D. Intraoperative radiotherapy of head and neck cancer. Arch Otolaryngol Head Neck Surg 1990;116:165-168.
17. Pinheiro AD, Foote RL, McCaffrey TV, et al. Intraoperative radiotherapy for head and neck skull base cancer. Head Neck 2002;25:217-226.
18. Guillamondegui OM, Byers RM, Luna MA, Chiminazzo H, Jesse RH, Fletcher GH. Aggressive surgery in treatment for parotid cancer: the role of adjunctive postoperative radiotherapy. Am J Roentgenol 1975;123:49-54.
19. Raux-Rakotomalala F, Houliat T, Martel J, Stoll D, Bebear JP, Darrouzet V. Adenoid cystic carcinoma of the head and neck: a review of 30 cases. Rev Laryngol Otol Rhinol 2003;124:235-241.
20. Spiro RH. Distant metastasis in adenoid cystic carcinoma of salivary origin. Am J Surg 1997;174:495-498.
21. Renehan A, Gleave EN, Hancock BD, Smith P, McGurk M. Long-term follow-up of over 1000 patients with salivary gland tumours treated in a single center. Br J Surg 1996;83:1750-1754.
22. Harbo G, Bundgaard T, Pedersen D, Sogaard H, Overgaard J. Prognostic indicators for malignant tumours of the parotid gland. Clin Otolaryngol 2002;27:512-516.
23. An J, Sun JY, Yuan Q, et al. Proteomics analysis of differentially expressed metastasis-associated proteins in adenoid cystic carcinoma cell lines of human salivary gland. Oral Oncol 2004;40:400-408.
24. Puthawala A, Syed AMN, Gamie S, Chen YJ, Londrc A, Nixon V. Interstitial low-dose-rate brachytherapy as a salvage treatment for recurrent head-and-neck cancers: long-term results. Int J Radiat Oncol Biol Phys 2001;51:354-362.
25. Hepel JT, Syed AM, Puthawala A, Sharma A, Frankel P. Salvage high-dose-rate (HDR) brachytherapy for recurrent head-and-neck cancer. Int J Radiat Oncol Biol Phys 2005;62:1444-1450.
26. Milano MT, Vokes EE, Salama JK, et al. Twice-daily reirradiation for recurrent and second primary head-and-neck cancer with gemcitabine, paclitaxel, and 5-fluorouracil chemotherapy. Int J Radiat Oncol Biol Phys 2005;61:1096-1106.
27. Machtay M, Rosenthal DI, Chalian AA, et al. Pilot study of postoperative reirradiation, chemotherapy, and amifostine after surgical salvage for recurrent head-and-neck cancer. Int J Radiat Oncol Biol Phys 2004;59:72-77.
28. Teh BS, Paulino AC, Butler EB. Reirradiation: exploring new territory in the therapy of recurrent head and neck cancer. Am J Clin Oncol 2005;28:472-473.
29. Haller JR, Mountain RE, Schuller DE, Nag S. Mortality and morbidity with intraoperative radiotherapy for head and neck cancer. Am J Otolaryngol 1996;17:308-310.
30. Schleicher UM, Phonias C, Spaeth J, Schlondorff G, Ammon J, Andreopoulos D. Intraoperative radiotherapy for pre-irradiated head and neck cancer. Radiother Oncol 2001;58:77-81.
31. Spaeth J, Andreopoulos D, Unger T, Beckman J, Ammon J, Schlondorff G. Intraoperative radiotherapy-5 years of experience in the palliative treatment of recurrent and advanced head and neck cancers. Oncology 1997;54:208-213.
32. Martinez-Monge R, Azinovic I, Alcalde J, et al. IORT in the management of locally advanced or recurrent head and neck cancer. Front Radiat Oncol 1997;31:122-125.
33. Laurie SA, Licitra L. Systemic therapy in the palliative management of advanced salivary gland cancers. J Clin Oncol 2006;24:2673-2678.